Mechanistic review of drug-induced steatohepatitis

Area of Science:

• Hepatology
• Toxicology
• Pharmacology

Background:

• Drug-induced steatohepatitis is a rare liver injury.
• Specific compounds cause steatohepatitis via mitochondrial toxicity.
• Chemotherapy-associated steatohepatitis (CASH) is an emerging clinical concern.

Purpose of the Study:

• To review the mechanisms of drug-induced steatohepatitis.
• To focus on cationic amphiphilic drugs and chemotherapeutic agents.
• To elucidate the pathways leading to drug-induced liver injury.

Main Methods:

• Literature review of drug-induced steatohepatitis mechanisms.
• Analysis of compounds causing steatohepatitis.
• Discussion of mitochondrial dysfunction and other cellular pathways.

Main Results:

• Mitochondrial toxicity (inhibition of beta-oxidation, respiration, oxidative phosphorylation) is a key mechanism.
• Other mechanisms include lysosomal phospholipid disruption, impaired lipid egress, DNA damage, and altered metabolic pathways.
• Cationic amphiphilic structures are common among causative agents.

Conclusions:

• Understanding drug-induced steatohepatitis mechanisms is crucial for patient safety.
• Cationic amphiphilic drugs and chemotherapeutics represent significant contributors.
• Further research into these pathways can inform therapeutic strategies and drug development.